Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing ’s Sarcoma
Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing’s Sarcoma
Molecular Therapy 24,
1478 (August 2016). doi:10.1038/mt.2016.86
Authors: Maurizio Ghisoli, Minal Barve, Robert Mennel, Carl Lenarsky, Staci Horvath, Gladice Wallraven, Beena O Pappen, Sam Whiting, Donald Rao, Neil Senzer & John Nemunaitis
Source: Molecular Therapy - Category: Genetics & Stem Cells Authors: Maurizio Ghisoli Minal Barve Robert Mennel Carl Lenarsky Staci Horvath Gladice Wallraven Beena O Pappen Sam Whiting Donald Rao Neil Senzer John Nemunaitis Source Type: research